$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period

(Singapore, 1968-1997 cases followed-up until 1997)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10Period approach, Calendar periodCohort approach, Calendar period
73-7778-8283-8788-9293-9773-7778-8283-8788-9293-97
C01-02Tongue26.330.222.832.638.324.028.228.320.341.0
C03-06Oral cavity31.325.837.240.640.425.933.427.232.644.5
C07-08Salivary gland57.967.679.963.770.246.559.375.369.473.8
C09Tonsil22.623.928.128.430.821.017.829.930.225.4
C11Nasopharynx31.438.539.951.256.828.733.638.146.153.2
C12-13Hypopharynx6.56.32.811.112.78.45.94.52.418.1
C15Oesophagus4.35.27.35.95.15.13.25.68.04.2
C16Stomach7.711.817.219.421.76.89.013.117.420.3
C18Colon33.232.440.048.050.529.531.534.442.549.5
C19-20Rectum21.427.832.939.447.618.322.329.035.443.9
C22Liver2.73.33.02.54.93.82.42.92.42.8
C23-24Gall bladder8.23.811.813.914.99.95.18.410.614.6
C25Pancreas4.54.89.03.95.77.25.24.96.26.7
C30-31Nose/Sinuses25.425.936.439.040.521.923.928.337.637.3
C32Larynx32.030.133.244.949.429.032.529.736.748.3
C33-34Lung5.55.96.06.47.74.24.76.26.06.5
C40-41Bone30.944.956.057.745.330.137.053.054.855.0
C44Other skin87.184.485.092.395.870.589.880.889.693.3
C47+C49Connective tissue54.139.256.651.050.244.948.141.650.651.8
C50Breast50.450.459.067.674.444.548.954.263.070.4
C53Cervix48.751.253.262.162.145.450.448.957.965.1
C54Corpus uteri46.964.471.777.479.147.751.365.876.275.7
C56Ovary50.148.260.265.865.745.646.654.459.166.7
C61Prostate43.638.438.850.757.437.341.535.445.652.4
C62Testis45.751.473.281.187.053.433.361.173.784.9
C64Kidney25.731.736.141.849.023.526.736.637.943.7
C67Urinary bladder38.345.050.358.761.035.435.744.255.361.3
C70-72Brain & nervous system19.334.525.227.328.413.822.631.525.423.9
C73Thyroid74.175.390.488.991.772.076.579.590.488.0
C81Hodgkin lymphoma42.937.540.152.474.030.438.544.341.056.2
C82-85+C96Non-Hodgkin lymphoma17.626.429.036.946.210.923.722.334.739.8
C90Multiple myeloma13.423.822.216.818.319.226.719.017.819.4
C91Lymphoid leukaemia13.618.016.116.733.53.720.013.618.016.4
C92-94Myeloid leukaemia5.93.59.79.519.64.74.96.610.016.3


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Singapore, 1993-1997 cases followed-up until 2001)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Singapore, 1993-1997)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997 (Singapore)
- Table7b: Number of cases by cancer site and calendar period (Singapore Cancer Registry, 1968-1997)
- Table8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)
- Table9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)